Quanome Technologies, Inc.

Aktienanalyse zu Quanome Technologies, Inc. (QNME)

$0.383

+0.046 (+11.96%)Zum Schluss

Loading chart…
Hoch
0.386
Eröffnung
0.360
Volumengewichteter Durchschnittskurs
0.38
Volumen
159.27K
Marktkap.
—
Tief
0.360
Umsatz
59.95K
EV/EBITDA, TTM
0.00

Lakeside Holding Limited is a holding company. The Company, through its subsidiary, Hupan Pharmaceutical (Hubei) Co., Ltd, is a medical injection and pharmaceutical distributor. It procures products from manufacturers, stores the products at designated warehouses, and distributes them to hospitals, distributors and other healthcare providers, primarily through agents.

quanometech.com

KI-Analyse of Quanome Technologies, Inc. (QNME)

Verkaufen

Given the current price of 0.38, the stock's RSI is at 37.591, indicating it is oversold. However, the forward P/E ratio is 0, and the gross margin has dropped to 7.96%, which raises concerns about profitability. The stock has seen a 20-day change of -48.35%, suggesting significant downward momentum. Therefore, it is advisable to sell rather than buy at this time.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Quanome Technologies, Inc. (QNME) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von .

Erwartetes KGV

5J-Durchschnitt P/E
Aktuelles P/E
0.00

Erwartetes EV/EBITDA

5J-Durchschnitt EV/EBITDA
Aktuelles EV/EBITDA
0.00

Erwartetes KUV

5J-Durchschnitt P/S
Aktuelles P/S
0.00

QNME FAQ – beantwortet von Alphio AI

Lakeside Holding Limited is a holding company. The Company, through its subsidiary, Hupan Pharmaceutical (Hubei) Co., Ltd, is a medical injection and pharmaceutical distributor. It procures products from manufacturers, stores the products at designated warehouses, and distributes them to hospitals, distributors and other healthcare providers, primarily through agents.

Given the current price of 0.38, the stock's RSI is at 37.591, indicating it is oversold. However, the forward P/E ratio is 0, and the gross margin has dropped to 7.96%, which raises concerns about profitability. The stock has seen a 20-day change of -48.35%, suggesting significant downward momentum. Therefore, it is advisable to sell rather than buy at this time.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln